Study of Occurrence of Non-Alcoholic Fatty Liver Disease (Nafld) in Polycystic Ovarian Syndrome (Pcos)
Main Article Content
Abstract
Article Details
References
Ehrmann DA. Polycystic ovary syndrome. NEngl J Med. 2005;352:1223 36.
Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J ClinEndocrinolMetab. 2004;89:2745 9.
Stein I, Leventhal M. Amenorrhea associated with bilateralpolycystic ovaries. Am J ObstetGynecol1935; 29: 181-91.
Bellentani S, Bedogni G, Tiribelli C. Liver and heart: A new link? J Hepatol. 2008; 49: 300 2.
Vassilatou E. Nonalcoholic fatty liver disease and polycystic ovary syndrome.World J Gastroenterol2014;20(26):8351-63.
AHMED FAISAL.,Liver Affection in polycystic Ovary Syndrome(PCOS).Med.J.CairoUniv 2012;80(2):117-22.
Rodin DA, Bano G, Bland JM, Taylor K, Nussey SS. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. ClinEndocrinol (Oxf) 1998;49:91 9.
Norman RJ, Mahabeer S, Master S. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic syndrome. FertilSteril. 1995;63:58 62.
Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: Is there a difference? ClinEndocrinol (Oxf) 2002;57:343 50.
Brown AJ, Tendler DA, McMurray RG, Setji TL. Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: Beneficial effect of modest weight loss and exercise on liver biopsy findings. EndocrPract. 2005; 11: 319 24.